1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck
Clinical trial NCT04150900 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04150900
- Sponsor
- University of Maryland, Baltimore
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-13
- Primary completion
- 2024-09-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.